TIP SHEET: Live Oak Health Fund Finds Value In Neglected Areas
26th Jul 2010 20:00
By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK (Dow Jones)--Mark Oelschlager treads a different path in running the Live Oak Health Sciences Fund (LOGSX). Unlike some health-care fund managers, he didn't come from a career in the pharmaceutical industry or a medical background, and he a
Read moreMARKET TALK: FDA Servers Down, Review Of Brilinta Delayed
26th Jul 2010 17:19
12:19 (Dow Jones) The posting of FDA's review of AstraZeneca's (AZN) proposed anticlotting drug Brilinta has been delayed because some of FDA's servers are down. The agency lost electricity yesterday after severe storms cut power to much of Montgomery County Maryland, where FDA is located. AZN off a
Read moreEARNINGS PREVIEW: AstraZeneca 2Q Seen Strong, 2H To Get Tough
26th Jul 2010 16:27
AstraZeneca PLC (AZN): 2Q Due: July 29 at 0600 GMT DJ Survey of 10 Analysts Average Net Profit: $1.94Bln, up 13% ($1.71Bln in 2Q 2009) Average Sales 2Q 2010: $8.03Bln, up 1% ($7.96Bln in 2Q 2009) Note: Evolution Securities says AstraZeneca looks set to release strong 2Q results helped by limite
Read moreEARNINGS FORECAST TABLE: AstraZeneca 2Q 2010
26th Jul 2010 15:22
FRANKFURT (Dow Jones)--The following is a summary of analysts' forecasts for AstraZeneca plc's (AZN) second-quarter results, based on a poll of 10 analysts by Dow Jones Newswires (in million USD, EPS, dividend in USD, target price in pence, according to IFRS). Earnings figures are scheduled to be re
Read moreTechMARK movers: Microsoft deal boosts ARM
23rd Jul 2010 15:09
Shares in chip designer ARM have jumped on the back of a new licensing deal with Microsoft. The architecture licence will extend the collaborative relationship that has been ongoing since 1997. AstraZeneca is sliding on worries over whether or not its new heart drug Brilinta will be approved by
Read moreWockhardt Gets US OK To Sell Generic Heart Drug
23rd Jul 2010 11:11
BANGALORE (Dow Jones)--Wockhardt Ltd. (532300.BY) Friday said it has received final approval from the U.S. Food & Drug Administration to sell a generic version of AstraZeneca PLC's (AZN) Toprol extended-release tablets for the treatment of heart problems. Wockhardt will immediately launch the pr
Read morePRESS RELEASE: AstraZeneca and Grace Hill Neighborhood Health Centers, Inc. Provide Medicines to Missouri's Uninsured
21st Jul 2010 14:00
WILMINGTON, Del., July 21 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) announced today that it is providing medicines at no cost to qualifying patients at Grace Hill Neighborhood Health Centers, Inc. in St. Louis. (Logo: http://photos.prnewswire.com/prnh/20091027/PH99766LOGO ) (Logo: ht
Read moreUPDATE:FDA Questions Benefit, Risks Of Avastin In Breast Cancer
16th Jul 2010 16:03
(Updates with additional information from FDA starting in second paragraph and adds background.) By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON (Dow Jones)--The Food and Drug Administration questioned the benefit of using Roche Holding AG's (RHHBY, ROG.VX) top-selling can
Read moreMARKET TALK: GSK May See Relief Rally On Avandia News >GSK.LN
15th Jul 2010 07:32
0632 GMT [Dow Jones] A modest rally in GlaxoSmithKline's (GSK.LN) shares could follow after the FDA voted in favor of keeping Avandia on the US market, says Citigroup. The brokerage notes the withdrawal of Avandia could have reduced the group's '11 EPS by 3.3%, or 6.4% in the event of worldwide with
Read moreUK MARKET TALK ROUNDUP: BROKERS COMMENTS
15th Jul 2010 07:32
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0632 GMT [Dow Jones] A modest rally in GlaxoSmithKline's (GSK.LN) shares could follow after the FDA voted in favor of keeping
Read moreUK SMALLCAP ROUNDUP: NXT's Cash Flow Pressured By Sales Fall
14th Jul 2010 12:30
Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps NXT PLC (NXT.LN), U.K. technology and licensing company, Wednesday said fiscal 2010 revenue is "significantly down" on last year, in spite of an improvem
Read morePRESS RELEASE: First nasal vaccine approved in Canada to prevent seasonal influenza
14th Jul 2010 12:05
Health Canada approval of FluMist(R) offers Canadians a safe,(1) more effective (2a,3a) option to protect against the flu MISSISSAUGA, ON, July 14 /CNW/ - AstraZeneca Canada Inc. announced today that Health Canada has approved FluMist(R) (Influenza Vaccine, Live, Attenuated) for the prevention
Read moreMARKET TALK: Citigroup Raises AstraZeneca Price Target
14th Jul 2010 09:41
0841 GMT [Dow Jones] Citigroup raises AstraZeneca (AZN.LN) price target to 3300p from 2800p. Says a look at Brilinta data ahead of the upcoming FDA advisory committee review leads the brokerage to take a more positive view on the outcome than previously. Thinks a recommendation for approval is more
Read moreUK MARKET TALK ROUNDUP: SHARES LOSING
14th Jul 2010 09:41
Stocks on the fall in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0841 GMT [Dow Jones] Citigroup raises AstraZeneca (AZN.LN) price target to 3300p from 2800p. Says a look at Brilinta data
Read moreUK SMALLCAP ROUNDUP: ASOS Revenue Boosted By Overseas Sales
14th Jul 2010 09:30
Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps ASOS PLC (ASC.LN), an online fashion retailer, Wednesday posted a 48% jump in first-quarter group revenue, helped by a more than doubling of overseas sal
Read more